DISEASE SCANNER
Global Incurable Diseases Tracker
Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
A fatty acid oxidation disorder where the body cannot break down medium-chain fatty acids for energy. Can lead to hypoglycemia, seizures, and brain damage during fasting or illness. Most common fatty acid oxidation disorder.
500.0K
21
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Newborn screening
- 2Acylcarnitine profile
- 3Urine organic acids
- 4Genetic testing (ACADM gene)
- 5Enzyme assay
- 6Prenatal testing
Prognosis
Excellent with proper management. Normal life expectancy and development if fasting avoided and emergency protocols followed. Risk of death if untreated during metabolic crisis.
Prevention
- Newborn screening
- Genetic counseling
- Avoid fasting
- Emergency protocols
- Medical alert bracelet
- Family education
Research Status
Newborn screening standard. Avoidance of fasting crucial. Medium-chain triglyceride supplementation. Carnitine supplementation. IV glucose during illness. Excellent outcome with proper management. Emergency protocols essential.
Affected Countries
Sources
- https://www.newbornscreening.info/Parents/fattyaciddisorders/MCADD.html
- https://www.mayoclinic.org/diseases-conditions/mcadd
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
- https://www.newbornscreening.info
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.